Inventor
Zhe CAI
Inventor
CN
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes14%
C07BGeneral methods of organic chemistry10%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
H05BElectric heating5%
LOC095%
Y02ATechnologies for adaptation to climate change5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023Patents assigned to FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD (1)· patent assignee history
2023–2026Based in CN· patent location history
2024–2026Patents assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (3)· patent assignee history
2025Patents assigned to CAI ZHE (2)· patent assignee history
2025Patents assigned to ZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD | 3 | 2024–2026 |
| CAI ZHEself | 2 | 2025 |
| FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD | 1 | 2023 |
| ZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 7 | 2023–2026 |